by Elec23 | Nov 5, 2024 | News&events
VisMederi is pleased to announce its inclusion in the distinguished 2023 list of the 300 fastest-growing companies, published by the Financial Times in partnership with Statista. VisMederi is proud to be ranked #188 among the leading organizations that have made great...
by Elec23 | Oct 8, 2024 | News&events
For those wishing to fully immerse themselves in the serological techniques required by regulatory agencies including the FDA, EMA, and PMD for the licensing and approval of viral vaccines, a 12-week program has been developed by Trialect and VisMederi Foundation....
by Elec23 | Sep 24, 2024 | News&events
Fondazione VisMederi has signed an agreement with Trialect Inc., USA, for the program entitled “Trialect Global Medical Education Program.” This initiative aims to provide short-term training and education for biomedical scientists and physicians to enhance the...
